CABOTEGRAVIR SODIUM

CABOTEGRAVIR SODIUM was reported 1605 times

CABOTEGRAVIR SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HLA-B*5701 ASSAY POSITIVE 2 0.4000
1 PROCTITIS CHLAMYDIAL 4 0.3636
2 LYMPHOMA AIDS RELATED 2 0.2500
3 PROCTITIS GONOCOCCAL 2 0.2000
4 GALLBLADDER AGENESIS 2 0.1818
5 JANEWAY LESION 2 0.1818
6 PERINATAL HIV INFECTION 2 0.1429
7 BLOOD HIV RNA BELOW ASSAY LIMIT 2 0.1333
8 HEPATITIS SYPHILITIC 2 0.1111
9 OROPHARYNGEAL GONOCOCCAL INFECTION 3 0.1111
10 VERTEBRAL LATERAL RECESS STENOSIS 2 0.1053
11 INJECTION SITE PANNICULITIS 2 0.1053
12 SYPHILIS TEST POSITIVE 2 0.0667
13 HEPATITIS B ANTIGEN POSITIVE 3 0.0625
14 CHRONIC ACTINIC DERMATITIS 2 0.0571
15 MEDIASTINAL CYST 1 0.0556
16 ADMINISTRATION SITE WARMTH 4 0.0488
17 ACUTE HEPATITIS B 16 0.0482
18 MUCOSAL EXCORIATION 2 0.0465
19 BOWENOID PAPULOSIS 1 0.0435
20 CONGENITAL AORTIC VALVE INCOMPETENCE 6 0.0432
21 HIV VIRAEMIA 8 0.0381
22 MONKEYPOX 10 0.0362
23 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 31 0.0355
24 VIRAL LOAD ABNORMAL 6 0.0343
25 AIDS RELATED COMPLICATION 2 0.0308
26 GASTRIC ADENOMA 2 0.0303
27 CSF VIRUS IDENTIFIED 2 0.0286
28 VIRAL LOAD INCREASED 110 0.0283
29 FEMORAL NERVE INJURY 2 0.0278
30 TROPONIN DECREASED 1 0.0278
31 BLOOD HIV RNA INCREASED 48 0.0264
32 FIRST BITE SYNDROME 1 0.0263
33 SYPHILIS 19 0.0261
34 HIV TEST FALSE POSITIVE 1 0.0256
35 ADMINISTRATION SITE NECROSIS 1 0.0250
36 CONGENITAL TRICUSPID VALVE INCOMPETENCE 5 0.0250
37 MISLEADING LABORATORY TEST RESULT 2 0.0241
38 VENTRICULAR HYPOPLASIA 6 0.0240
39 ATRIOVENTRICULAR SEPTAL DEFECT 10 0.0213
40 ADMINISTRATION SITE DISCOMFORT 4 0.0212
41 INJECTION SITE GRANULOMA 5 0.0211
42 BETA 2 MICROGLOBULIN URINE INCREASED 3 0.0210
43 ENCAPSULATION REACTION 2 0.0194
44 SUBSTANCE USE 30 0.0192
45 HEPATITIS B REACTIVATION 54 0.0170
46 ADMINISTRATION SITE NODULE 1 0.0167
47 BENIGN ETHNIC NEUTROPENIA 2 0.0156
48 INJECTION SITE MOVEMENT IMPAIRMENT 2 0.0156
49 CSF HIV ESCAPE SYNDROME 2 0.0145
50 ABSCESS STERILE 2 0.0135
51 ABSCESS SOFT TISSUE 2 0.0130
52 VIROLOGIC FAILURE 66 0.0123
53 COUGH VARIANT ASTHMA 1 0.0119
54 ADMINISTRATION SITE OEDEMA 1 0.0116
55 PRIMARY EFFUSION LYMPHOMA 1 0.0116
56 TONGUE FUNGAL INFECTION 2 0.0116
57 DRUG RESISTANCE MUTATION 2 0.0112
58 SINGLE COMPONENT OF A TWO-COMPONENT PRODUCT ADMINISTERED 1 0.0111
59 ADMINISTRATION SITE INDURATION 1 0.0111
60 HEPATITIS B 65 0.0108
61 HEPATITIS B ANTIBODY POSITIVE 2 0.0106
62 MYOCARDIAL OEDEMA 4 0.0101
63 AMOEBIC DYSENTERY 1 0.0101
64 VIRAL MUTATION IDENTIFIED 36 0.0098
65 CD4 LYMPHOCYTES ABNORMAL 2 0.0095
66 PREGNANCY WITH INJECTABLE CONTRACEPTIVE 2 0.0094
67 PSEUDOCHOLELITHIASIS 1 0.0093
68 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0090
69 MOTOR NEURONE DISEASE 4 0.0082
70 GRANULOMATOUS DERMATITIS 2 0.0082
71 UNWANTED PREGNANCY 1 0.0073
72 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 2 0.0072
73 INJECTED LIMB MOBILITY DECREASED 1 0.0070
74 ADMINISTRATION SITE PAIN 8 0.0069
75 PATHOGEN RESISTANCE 61 0.0067
76 LIMB FRACTURE 1 0.0067
77 CHLAMYDIAL INFECTION 5 0.0066
78 VAGINAL LESION 2 0.0065
79 CHRONIC TONSILLITIS 1 0.0065
80 VIRAEMIA 9 0.0065
81 MENINGOCOCCAL INFECTION 2 0.0063
82 PLASTIC SURGERY 2 0.0062
83 HEPATITIS B DNA INCREASED 4 0.0059
84 MYOSCLEROSIS 2 0.0054
85 HYPOMETABOLISM 2 0.0052
86 FAT NECROSIS 3 0.0049
87 VAGINAL ULCERATION 2 0.0048
88 LYMPH GLAND INFECTION 2 0.0044
89 MUSCLE MASS 2 0.0044
90 BODY MASS INDEX DECREASED 2 0.0043
91 FACIAL ASYMMETRY 4 0.0042
92 PNEUMONIA HAEMOPHILUS 2 0.0041
93 PHARYNGITIS BACTERIAL 1 0.0039
94 ACQUIRED IMMUNODEFICIENCY SYNDROME 2 0.0039
95 CRIME 1 0.0038
96 HYPERMETABOLISM 2 0.0038
97 MEASLES 2 0.0037
98 GONORRHOEA 1 0.0037
99 MORNING SICKNESS 2 0.0037
100 ANTICOAGULANT THERAPY 1 0.0035
101 INJECTION SITE OEDEMA 6 0.0035
102 LARYNGEAL STENOSIS 2 0.0035
103 GENITAL PARAESTHESIA 1 0.0034
104 LIP ULCERATION 4 0.0034
105 AKINESIA 7 0.0034
106 INDURATION 6 0.0034
107 THYROID CYST 2 0.0034
108 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 2 0.0033
109 PALATAL DISORDER 2 0.0033
110 LIPOHYPERTROPHY 2 0.0032
111 INJECTION SITE ABSCESS 8 0.0032
112 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
113 SUBSTANCE DEPENDENCE 2 0.0030
114 SOFT TISSUE NECROSIS 2 0.0029
115 PSEUDOSTROKE 1 0.0029
116 RADICULAR PAIN 1 0.0029
117 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0029
118 ALCOHOL INTOLERANCE 2 0.0028
119 CATHETER REMOVAL 1 0.0028
120 TRYPTASE INCREASED 2 0.0028
121 TINEA VERSICOLOUR 1 0.0028
122 AMNIOTIC CAVITY INFECTION 2 0.0028
123 LOCAL REACTION 2 0.0027
124 COMPLICATION OF PREGNANCY 2 0.0026
125 ASPARTATE AMINOTRANSFERASE ABNORMAL 4 0.0026
126 CREATINE KINASE INCREASED 2 0.0026
127 CARDIOVASCULAR SYMPTOM 1 0.0026
128 HEART DISEASE CONGENITAL 9 0.0025
129 HEPATITIS E 4 0.0025
130 LIP ERYTHEMA 2 0.0025
131 HEPATITIS VIRAL 2 0.0025
132 VACCINATION FAILURE 4 0.0024
133 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
134 MUCOSAL EROSION 2 0.0022
135 GASTRIC OPERATION 2 0.0022
136 ABSCESS LIMB 9 0.0021
137 INJECTION SITE DISCHARGE 11 0.0020
138 MUCOSAL DISORDER 2 0.0020
139 CENTRAL VENOUS CATHETERISATION 6 0.0020
140 INJECTION SITE NECROSIS 4 0.0020
141 BREAST NEOPLASM 2 0.0019
142 ALANINE AMINOTRANSFERASE ABNORMAL 4 0.0019
143 DRUG LEVEL ABNORMAL 1 0.0019
144 CD4 LYMPHOCYTES DECREASED 4 0.0019
145 GASTROINTESTINAL TRACT IRRITATION 2 0.0018
146 PROCTITIS 5 0.0018
147 STRESS AT WORK 2 0.0018
148 PATENT DUCTUS ARTERIOSUS 7 0.0018
149 DYSLEXIA 2 0.0017
150 FOLATE DEFICIENCY 2 0.0017
151 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
152 DRUG LEVEL DECREASED 17 0.0017
153 INJECTION SITE NODULE 18 0.0016
154 INJECTION SITE DISCOMFORT 17 0.0016
155 PALATAL OEDEMA 2 0.0016
156 RECTAL TENESMUS 2 0.0016
157 INJECTION SITE INFLAMMATION 8 0.0016
158 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
159 GASTRIC ULCER PERFORATION 2 0.0016
160 UNDERWEIGHT 3 0.0015
161 DISCHARGE 2 0.0014
162 IMMUNISATION REACTION 1 0.0014
163 CARDIAC FIBRILLATION 2 0.0014
164 IMPETIGO 2 0.0013
165 MARASMUS 2 0.0013
166 BACTERIAL VAGINOSIS 2 0.0013
167 ESCHERICHIA BACTERAEMIA 3 0.0013
168 PRODUCT CONFUSION 1 0.0013
169 VARICELLA 3 0.0013
170 THYROID HORMONES DECREASED 1 0.0013
171 ENURESIS 5 0.0012
172 TONGUE ERYTHEMA 1 0.0012
173 GASTRIC DILATATION 2 0.0012
174 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 2 0.0012
175 HEPATITIS A 1 0.0012
176 SKIN WOUND 2 0.0012
177 TYPE I HYPERSENSITIVITY 4 0.0011
178 PANCREATIC FAILURE 2 0.0011
179 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
180 MACULOPATHY 4 0.0011
181 CONJUNCTIVAL HYPERAEMIA 4 0.0011
182 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
183 OPHTHALMIC HERPES ZOSTER 2 0.0011
184 ESSENTIAL HYPERTENSION 2 0.0011
185 ERECTILE DYSFUNCTION 28 0.0011
186 RASH MORBILLIFORM 3 0.0011
187 PHARYNGEAL HYPOAESTHESIA 1 0.0011
188 PSYCHOTIC DISORDER 31 0.0010
189 VENTRICULAR SEPTAL DEFECT 6 0.0010
190 EPIDERMAL NECROSIS 1 0.0010
191 INJECTION SITE INDURATION 13 0.0010
192 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
193 IMPULSE-CONTROL DISORDER 2 0.0010
194 PHARYNGEAL ERYTHEMA 2 0.0009
195 HEPATITIS ACUTE 6 0.0009
196 SUPERFICIAL INJURY OF EYE 1 0.0009
197 PILOERECTION 1 0.0009
198 INJECTION SITE INFECTION 3 0.0009
199 BIPOLAR I DISORDER 2 0.0009
200 IMMEDIATE POST-INJECTION REACTION 1 0.0009
201 TONGUE BLISTERING 2 0.0009
202 TONGUE ULCERATION 3 0.0009
203 CHRONIC GASTRITIS 2 0.0009
204 RENAL COLIC 2 0.0009
205 URINE ABNORMALITY 4 0.0009
206 HAEMATOCRIT INCREASED 2 0.0009
207 PANCREATITIS NECROTISING 2 0.0009
208 LICHEN PLANUS 2 0.0009
209 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
210 PRURITUS ALLERGIC 1 0.0009
211 BLOOD IMMUNOGLOBULIN E INCREASED 2 0.0008
212 ACUTE PSYCHOSIS 2 0.0008
213 PROTEIN URINE PRESENT 4 0.0008
214 OVARIAN CYST RUPTURED 1 0.0008
215 ADENOCARCINOMA PANCREAS 1 0.0008
216 PHYSICAL DECONDITIONING 2 0.0008
217 TRISMUS 4 0.0008
218 VENTRICULAR DYSFUNCTION 2 0.0008
219 PERIORBITAL OEDEMA 4 0.0008
220 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
221 PRODUCT ADMINISTRATION ERROR 15 0.0007
222 HYPERURICAEMIA 3 0.0007
223 MACULE 2 0.0007
224 VENTRICULAR FIBRILLATION 8 0.0007
225 DIABETIC COMA 2 0.0007
226 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
227 JOINT LOCK 2 0.0007
228 GENITAL RASH 1 0.0007
229 TRACHEOSTOMY 1 0.0007
230 NEOPLASM 8 0.0007
231 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
232 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
233 EYELID OEDEMA 8 0.0007
234 NEGATIVE THOUGHTS 2 0.0007
235 STRIDOR 2 0.0007
236 CONJUNCTIVITIS ALLERGIC 1 0.0007
237 ATYPICAL PNEUMONIA 2 0.0007
238 HEPATITIS 17 0.0007
239 CRANIOCEREBRAL INJURY 2 0.0007
240 AGGRESSION 33 0.0007
241 HAEMOGLOBIN INCREASED 3 0.0007
242 GENITAL HERPES 1 0.0007
243 ECTOPIC PREGNANCY 2 0.0006
244 FIBROSIS 2 0.0006
245 BRAIN DEATH 2 0.0006
246 CHOLANGITIS 4 0.0006
247 PREGNANCY WITH IMPLANT CONTRACEPTIVE 3 0.0006
248 INJECTION SITE HYPERSENSITIVITY 2 0.0006
249 TRANSCRIPTION MEDICATION ERROR 1 0.0006
250 EOSINOPHILIC PNEUMONIA 2 0.0006
251 PHARYNGEAL PARAESTHESIA 1 0.0006
252 SUBSTANCE USE DISORDER 2 0.0006
253 HEPATIC CYTOLYSIS 8 0.0006
254 LIVER ABSCESS 2 0.0006
255 HERPES SIMPLEX 4 0.0006
256 POLYURIA 5 0.0006
257 INJECTION SITE ATROPHY 1 0.0006
258 INJECTION RELATED REACTION 1 0.0006
259 NEAR DEATH EXPERIENCE 2 0.0006
260 TONSILLAR HYPERTROPHY 1 0.0006
261 WRONG PRODUCT ADMINISTERED 4 0.0006
262 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
263 MICTURITION DISORDER 2 0.0006
264 HYPERTRANSAMINASAEMIA 4 0.0006
265 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
266 ERYTHEMA NODOSUM 2 0.0006
267 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
268 DEPRESSIVE SYMPTOM 2 0.0006
269 MUSCLE ATROPHY 7 0.0006
270 CUTANEOUS VASCULITIS 2 0.0005
271 ASTHMATIC CRISIS 2 0.0005
272 AMYLASE INCREASED 2 0.0005
273 ABORTION INDUCED 5 0.0005
274 CARDIOPULMONARY FAILURE 2 0.0005
275 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
276 ANORECTAL DISORDER 1 0.0005
277 INTRACRANIAL ANEURYSM 2 0.0005
278 HEPATITIS C 6 0.0005
279 CHANGE OF BOWEL HABIT 1 0.0005
280 HELICOBACTER INFECTION 5 0.0005
281 ANAPHYLACTOID REACTION 2 0.0005
282 AORTIC DISSECTION 2 0.0005
283 SKIN INDURATION 1 0.0005
284 INSULIN RESISTANCE 1 0.0005
285 SELF-INJURIOUS IDEATION 2 0.0005
286 TREATMENT NONCOMPLIANCE 26 0.0005
287 ABORTION SPONTANEOUS 19 0.0005
288 LUNG NEOPLASM 2 0.0005
289 DEREALISATION 1 0.0005
290 INJECTION SITE INDENTATION 1 0.0005
291 CHAPPED LIPS 2 0.0005
292 MONOPLEGIA 2 0.0005
293 NODULE 6 0.0005
294 RHINITIS ALLERGIC 2 0.0004
295 EXPOSURE DURING PREGNANCY 27 0.0004
296 SKIN TIGHTNESS 2 0.0004
297 VAGINAL INFECTION 2 0.0004
298 PUSTULE 1 0.0004
299 SARCOIDOSIS 2 0.0004
300 PARAESTHESIA ORAL 6 0.0004
301 PRODUCT DISPENSING ERROR 9 0.0004
302 PHARYNGEAL SWELLING 4 0.0004
303 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
304 SYNCOPE 40 0.0004
305 CORONARY ARTERY STENOSIS 2 0.0004
306 DYSLIPIDAEMIA 2 0.0004
307 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
308 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
309 ABSCESS 6 0.0004
310 FEELING HOT 23 0.0004
311 ANAL FISSURE 2 0.0004
312 OVERWEIGHT 2 0.0004
313 PRESYNCOPE 9 0.0004
314 EAR CONGESTION 1 0.0004
315 LIP BLISTER 1 0.0004
316 HYPERTENSIVE CRISIS 4 0.0004
317 ANGIOPATHY 2 0.0004
318 INJECTION SITE PAIN 109 0.0004
319 PRODUCT COMPLAINT 9 0.0004
320 CHOLECYSTITIS ACUTE 2 0.0004
321 OESOPHAGEAL STENOSIS 1 0.0004
322 INJECTION SITE MASS 13 0.0004
323 HEART VALVE INCOMPETENCE 1 0.0003
324 MYOCARDITIS 4 0.0003
325 PHARYNGEAL DISORDER 1 0.0003
326 NIGHTMARE 12 0.0003
327 VOMITING PROJECTILE 1 0.0003
328 SKIN WARM 2 0.0003
329 LUMBAR SPINAL STENOSIS 1 0.0003
330 MYOSITIS 3 0.0003
331 POLYNEUROPATHY 4 0.0003
332 HIV INFECTION 1 0.0003
333 TENSION 2 0.0003
334 DYSAESTHESIA 1 0.0003
335 LIVER FUNCTION TEST INCREASED 7 0.0003
336 ANAPHYLACTIC REACTION 18 0.0003
337 PIGMENTATION DISORDER 2 0.0003
338 FOREIGN BODY IN THROAT 1 0.0003
339 SUICIDAL IDEATION 29 0.0003
340 DRUG RESISTANCE 8 0.0003
341 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 56 0.0003
342 SKIN EROSION 1 0.0003
343 VITREOUS FLOATERS 3 0.0003
344 DYSGRAPHIA 2 0.0003
345 PRODUCT DOSE OMISSION ISSUE 89 0.0003
346 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
347 POST-TRAUMATIC STRESS DISORDER 2 0.0003
348 EPILEPSY 9 0.0003
349 ECCHYMOSIS 2 0.0003
350 VENTRICULAR EXTRASYSTOLES 3 0.0003
351 EOSINOPHILIA 5 0.0003
352 PAPULE 2 0.0003
353 SUDDEN DEATH 3 0.0003
354 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
355 FEAR OF INJECTION 2 0.0003
356 TOOTHACHE 5 0.0003
357 ORAL DISORDER 2 0.0003
358 LIP SWELLING 9 0.0003
359 RASH MACULO-PAPULAR 6 0.0003
360 PREMATURE BABY 8 0.0003
361 DISSOCIATION 2 0.0003
362 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003
363 VASCULITIS 3 0.0003
364 NICOTINE DEPENDENCE 2 0.0003
365 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
366 ABNORMAL DREAMS 7 0.0003
367 TREATMENT FAILURE 21 0.0003
368 BLOOD PRESSURE ABNORMAL 5 0.0003
369 HYPERLIPIDAEMIA 3 0.0003
370 OESOPHAGEAL CANDIDIASIS 1 0.0003
371 SCIATICA 4 0.0003
372 SENSORY LOSS 2 0.0002
373 NIGHT SWEATS 8 0.0002
374 MUSCULOSKELETAL PAIN 13 0.0002
375 MUSCLE DISORDER 2 0.0002
376 DYSKINESIA 10 0.0002
377 ASPHYXIA 2 0.0002
378 BLOOD PRESSURE DECREASED 16 0.0002
379 EOSINOPHIL COUNT INCREASED 2 0.0002
380 ATRIAL SEPTAL DEFECT 2 0.0002
381 DERMATITIS ALLERGIC 3 0.0002
382 SENSATION OF FOREIGN BODY 2 0.0002
383 OESOPHAGEAL CARCINOMA 7 0.0002
384 TONGUE DISCOMFORT 1 0.0002
385 AORTIC VALVE INCOMPETENCE 1 0.0002
386 FACIAL PARALYSIS 2 0.0002
387 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
388 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
389 MENTAL DISORDER 10 0.0002
390 ORAL CANDIDIASIS 3 0.0002
391 IMMUNOSUPPRESSION 2 0.0002
392 PRODUCT COMMUNICATION ISSUE 2 0.0002
393 STEVENS-JOHNSON SYNDROME 5 0.0002
394 ISCHAEMIC STROKE 4 0.0002
395 HEAVY MENSTRUAL BLEEDING 2 0.0002
396 UVEITIS 3 0.0002
397 TACHYPNOEA 3 0.0002
398 OPTIC NEURITIS 2 0.0002
399 MOOD ALTERED 6 0.0002
400 C-REACTIVE PROTEIN INCREASED 8 0.0002
401 NERVE COMPRESSION 2 0.0002
402 CONJUNCTIVITIS 4 0.0002
403 PRODUCT DISTRIBUTION ISSUE 2 0.0002
404 PERSONALITY CHANGE 2 0.0002
405 ERYTHEMA MULTIFORME 2 0.0002
406 FEELING OF DESPAIR 1 0.0002
407 PERFORMANCE STATUS DECREASED 1 0.0002
408 APPENDICITIS 2 0.0002
409 FLANK PAIN 2 0.0002
410 SKIN REACTION 3 0.0002
411 ARTERIOSCLEROSIS 2 0.0002
412 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
413 BRONCHOSPASM 3 0.0002
414 HYPOVOLAEMIC SHOCK 1 0.0002
415 HYPERCHOLESTEROLAEMIA 2 0.0002
416 SINUS BRADYCARDIA 2 0.0002
417 RASH VESICULAR 1 0.0002
418 HAEMORRHOIDS 4 0.0002
419 DEPRESSION 46 0.0002
420 TOXIC SKIN ERUPTION 2 0.0002
421 EMPHYSEMA 2 0.0002
422 SUICIDE ATTEMPT 12 0.0002
423 VAGINAL DISCHARGE 2 0.0002
424 DYSPHORIA 1 0.0002
425 PRODUCT USE ISSUE 37 0.0002
426 TOOTH ABSCESS 2 0.0002
427 MOTOR DYSFUNCTION 2 0.0002
428 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
429 CHEST DISCOMFORT 20 0.0002
430 EAR DISCOMFORT 2 0.0002
431 TENDERNESS 2 0.0002
432 MOUTH ULCERATION 4 0.0002
433 SCRATCH 2 0.0002
434 DISEASE RECURRENCE 9 0.0002
435 HYPERHIDROSIS 24 0.0002
436 JAUNDICE 5 0.0002
437 THROAT TIGHTNESS 5 0.0002
438 RASH PRURITIC 10 0.0002
439 SWELLING FACE 12 0.0002
440 PALLOR 5 0.0002
441 DIABETES MELLITUS 14 0.0002
442 EYE DISORDER 6 0.0002
443 MYALGIA 31 0.0002
444 TOOTH FRACTURE 2 0.0002
445 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
446 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
447 PRODUCT LEAKAGE 1 0.0002
448 FISTULA 2 0.0002
449 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
450 CHOLECYSTECTOMY 2 0.0002
451 ANGINA PECTORIS 5 0.0002
452 INJECTION SITE REACTION 12 0.0002
453 GASTRIC HAEMORRHAGE 2 0.0002
454 ENTEROCOLITIS 1 0.0002
455 PERICARDIAL EFFUSION 4 0.0002
456 HYPERVENTILATION 1 0.0002
457 CHILLS 20 0.0002
458 URINE ODOUR ABNORMAL 1 0.0002
459 ACUTE MYOCARDIAL INFARCTION 5 0.0002
460 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
461 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
462 TACHYCARDIA 15 0.0002
463 OCULAR HYPERAEMIA 8 0.0002
464 BLOOD CREATININE INCREASED 11 0.0002
465 PRODUCT PRESCRIBING ERROR 4 0.0002
466 ILL-DEFINED DISORDER 10 0.0002
467 DISCOMFORT 10 0.0002
468 CYTOPENIA 2 0.0002
469 LARYNGEAL OEDEMA 1 0.0002
470 INJECTION SITE EXTRAVASATION 2 0.0002
471 EYE SWELLING 6 0.0002
472 CYST 2 0.0002
473 ILEUS 2 0.0002
474 HEPATIC FUNCTION ABNORMAL 6 0.0002
475 SECRETION DISCHARGE 2 0.0002
476 NASAL DRYNESS 1 0.0002
477 FOREIGN BODY SENSATION IN EYES 1 0.0002
478 INJECTION SITE SWELLING 12 0.0002
479 THERAPY CESSATION 8 0.0002
480 GLAUCOMA 3 0.0002
481 SKIN ULCER 4 0.0002
482 EXPOSURE VIA SKIN CONTACT 4 0.0002
483 CHOKING 3 0.0002
484 PLATELET COUNT INCREASED 2 0.0002
485 PRODUCT PREPARATION ISSUE 1 0.0002
486 CORONAVIRUS INFECTION 1 0.0002
487 STOMATITIS 9 0.0001
488 FEEDING DISORDER 3 0.0001
489 OEDEMA 8 0.0001
490 BODY TEMPERATURE INCREASED 3 0.0001
491 INJECTION SITE WARMTH 3 0.0001
492 RIB FRACTURE 3 0.0001
493 MASS 2 0.0001
494 RASH MACULAR 5 0.0001
495 SLEEP DISORDER 10 0.0001
496 LYMPHOPENIA 2 0.0001
497 SEASONAL ALLERGY 2 0.0001
498 HAND FRACTURE 1 0.0001
499 PARALYSIS 2 0.0001
500 TONGUE DISORDER 1 0.0001
501 HYPERTHYROIDISM 2 0.0001
502 DERMATITIS BULLOUS 1 0.0001
503 INJECTION SITE HAEMATOMA 2 0.0001
504 PRODUCT PRESCRIBING ISSUE 3 0.0001
505 LIVER FUNCTION TEST ABNORMAL 4 0.0001
506 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
507 GASTROENTERITIS 2 0.0001
508 DYSPHAGIA 13 0.0001
509 MAJOR DEPRESSION 1 0.0001
510 ANGIOEDEMA 6 0.0001
511 PULMONARY MASS 2 0.0001
512 PYREXIA 46 0.0001
513 HEPATIC FAILURE 4 0.0001
514 DEPRESSED MOOD 7 0.0001
515 URTICARIA 22 0.0001
516 NEPHROLITHIASIS 6 0.0001
517 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
518 FOOD ALLERGY 1 0.0001
519 LYMPHOMA 2 0.0001
520 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
521 SWOLLEN TONGUE 4 0.0001
522 FLUSHING 13 0.0001
523 ERYTHEMA 26 0.0001
524 GINGIVAL PAIN 1 0.0001
525 MOOD SWINGS 4 0.0001
526 TRANSPLANT REJECTION 1 0.0001
527 BACK PAIN 29 0.0001
528 NEURALGIA 3 0.0001
529 POST PROCEDURAL INFECTION 1 0.0001
530 SHOCK HAEMORRHAGIC 1 0.0001
531 HICCUPS 1 0.0001
532 PHOTOSENSITIVITY REACTION 2 0.0001
533 MUSCLE INJURY 1 0.0001
534 CYTOMEGALOVIRUS INFECTION 2 0.0001
535 SKIN DISORDER 4 0.0001
536 RASH 52 0.0001
537 ABDOMINAL DISCOMFORT 20 0.0001
538 EYE PRURITUS 4 0.0001
539 PERICARDITIS 2 0.0001
540 TYPE 2 DIABETES MELLITUS 4 0.0001
541 CIRCULATORY COLLAPSE 2 0.0001
542 ANAPHYLACTIC SHOCK 3 0.0001
543 MUSCULOSKELETAL DISCOMFORT 2 0.0001
544 PYELONEPHRITIS 1 0.0001
545 JOINT STIFFNESS 3 0.0001
546 NEUROTOXICITY 2 0.0001
547 GASTRITIS 3 0.0001
548 SPINAL OSTEOARTHRITIS 1 0.0001
549 COLD SWEAT 2 0.0001
550 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
551 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
552 MENSTRUATION IRREGULAR 3 0.0001
553 MALAISE 49 0.0001
554 MOBILITY DECREASED 8 0.0001
555 DISTURBANCE IN ATTENTION 6 0.0001
556 BLOOD BILIRUBIN INCREASED 3 0.0001
557 OROPHARYNGEAL DISCOMFORT 1 0.0001
558 PELVIC PAIN 2 0.0001
559 LOSS OF CONSCIOUSNESS 14 0.0001
560 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
561 PNEUMONIA BACTERIAL 1 0.0001
562 PRODUCT USE IN UNAPPROVED INDICATION 27 0.0001
563 RETINAL DETACHMENT 1 0.0001
564 CHEST PAIN 20 0.0001
565 HYPERSENSITIVITY 20 0.0001
566 AGRANULOCYTOSIS 2 0.0001
567 HEPATIC STEATOSIS 2 0.0001
568 WOUND 3 0.0001
569 BLOOD CHOLESTEROL INCREASED 5 0.0001
570 BACTERIAL INFECTION 2 0.0001
571 HYPONATRAEMIA 6 0.0001
572 SPUTUM DISCOLOURED 1 0.0001
573 MUSCULOSKELETAL DISORDER 2 0.0001
574 HYPERSOMNIA 3 0.0001
575 ACUTE RESPIRATORY FAILURE 2 0.0001
576 HERNIA 2 0.0001
577 DIZZINESS POSTURAL 1 0.0001
578 AUTOIMMUNE DISORDER 1 0.0001
579 URINARY INCONTINENCE 3 0.0001
580 RENAL INJURY 3 0.0001
581 ADVERSE DRUG REACTION 9 0.0001
582 SALIVARY HYPERSECRETION 1 0.0001
583 LACRIMATION INCREASED 3 0.0001
584 GAIT DISTURBANCE 19 0.0001
585 CELLULITIS 5 0.0001
586 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
587 INTENTIONAL SELF-INJURY 2 0.0001
588 EUPHORIC MOOD 1 0.0001
589 OROPHARYNGEAL PAIN 9 0.0001
590 PERITONITIS 2 0.0001
591 EYE DISCHARGE 1 0.0001
592 DRUG-INDUCED LIVER INJURY 3 0.0001
593 PANCREATITIS 5 0.0001
594 BRADYCARDIA 5 0.0001
595 PALPITATIONS 11 0.0001
596 RETCHING 2 0.0001
597 BREAST PAIN 1 0.0001
598 IRRITABLE BOWEL SYNDROME 2 0.0001
599 OSTEONECROSIS 3 0.0001
600 DENTAL CARIES 1 0.0001
601 LIVER DISORDER 4 0.0001
602 TRANSAMINASES INCREASED 2 0.0001
603 NECK PAIN 5 0.0001
604 MALNUTRITION 1 0.0001
605 ORAL PAIN 2 0.0001
606 HEADACHE 56 0.0001
607 SNEEZING 2 0.0001
608 THROAT IRRITATION 4 0.0001
609 PANCREATITIS ACUTE 2 0.0001
610 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
611 ANGER 3 0.0001
612 DERMATITIS CONTACT 1 0.0001
613 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
614 EYE IRRITATION 5 0.0001
615 DRY MOUTH 7 0.0001
616 RENAL DISORDER 4 0.0001
617 COMA 4 0.0001
618 CHOLECYSTITIS 1 0.0001
619 DRUG INTOLERANCE 8 0.0001
620 PHARYNGITIS 1 0.0001
621 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
622 LEUKOPENIA 4 0.0001
623 PRODUCT STORAGE ERROR 7 0.0001
624 COVID-19 14 0.0001
625 GASTRIC CANCER 2 0.0001
626 HAEMATEMESIS 2 0.0001
627 HYPOPHAGIA 2 0.0001
628 DYSPNOEA 44 0.0001
629 ANXIETY 22 0.0001
630 HAEMATOMA 2 0.0001
631 CEREBROVASCULAR ACCIDENT 13 0.0001
632 CONDITION AGGRAVATED 23 0.0001
633 HYPERTENSION 16 0.0001
634 ADVERSE REACTION 1 0.0001
635 INJECTION SITE HAEMORRHAGE 6 0.0001
636 NEOPLASM MALIGNANT 5 0.0001
637 QUALITY OF LIFE DECREASED 1 0.0001
638 MYOCARDIAL INFARCTION 13 0.0001
639 EXTRA DOSE ADMINISTERED 3 0.0001
640 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
641 NEUTROPENIA 10 0.0001
642 NAUSEA 58 0.0001
643 FATIGUE 57 0.0001
644 OFF LABEL USE 64 0.0001
645 LUNG NEOPLASM MALIGNANT 3 0.0001
646 PRURITUS 28 0.0001
647 CARDIO-RESPIRATORY ARREST 3 0.0001
648 ROAD TRAFFIC ACCIDENT 3 0.0001
649 HAEMOPTYSIS 2 0.0001
650 HOSPITALISATION 11 0.0001
651 BLISTER 4 0.0001
652 HEPATOCELLULAR INJURY 1 0.0001
653 PAIN 43 0.0001
654 PARAESTHESIA 11 0.0001
655 ANOSMIA 1 0.0001
656 ILLNESS 7 0.0001
657 INSOMNIA 18 0.0001
658 COLON CANCER 1 0.0001
659 ASTHENIA 25 0.0001
660 APHASIA 2 0.0001
661 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
662 VERTIGO 4 0.0001
663 MUSCULOSKELETAL CHEST PAIN 1 0.0001
664 COGNITIVE DISORDER 3 0.0001
665 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
666 VOMITING 30 0.0001
667 ARRHYTHMIA 3 0.0001
668 PULMONARY EMBOLISM 6 0.0001
669 OBESITY 1 0.0001
670 FEELING ABNORMAL 15 0.0001
671 MOVEMENT DISORDER 2 0.0001
672 DEEP VEIN THROMBOSIS 4 0.0001
673 INCORRECT DOSE ADMINISTERED 14 0.0001
674 DYSPEPSIA 6 0.0001
675 IMPAIRED HEALING 2 0.0001
676 INFLUENZA LIKE ILLNESS 5 0.0001
677 STAPHYLOCOCCAL INFECTION 2 0.0001
678 INFUSION RELATED REACTION 4 0.0001
679 VIRAL INFECTION 2 0.0001
680 GAIT INABILITY 2 0.0001
681 SOMNOLENCE 12 0.0001
682 RENAL IMPAIRMENT 5 0.0001
683 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
684 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
685 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
686 SPEECH DISORDER 3 0.0001
687 SYRINGE ISSUE 1 0.0001
688 COUGH 16 0.0001
689 HYPERKALAEMIA 2 0.0001
690 HYPOXIA 2 0.0001
691 LYMPHADENOPATHY 2 0.0001
692 INJECTION SITE ERYTHEMA 7 0.0001
693 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
694 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
695 MYELOSUPPRESSION 2 0.0001
696 PANIC ATTACK 2 0.0001
697 RESTLESSNESS 2 0.0001
698 DYSURIA 2 0.0001
699 OXYGEN SATURATION DECREASED 3 0.0001
700 DYSPNOEA EXERTIONAL 2 0.0001
701 HOT FLUSH 4 0.0001
702 ARTHRALGIA 22 0.0001
703 FOOT FRACTURE 1 0.0001
704 GASTRIC ULCER 1 0.0001
705 NEUROPATHY PERIPHERAL 5 0.0001
706 FEELING JITTERY 1 0.0001
707 HERPES ZOSTER 3 0.0001
708 DIZZINESS 26 0.0001
709 POST PROCEDURAL COMPLICATION 1 0.0001
710 SEIZURE 6 0.0001
711 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
712 WEIGHT DECREASED 14 0.0001
713 FULL BLOOD COUNT DECREASED 1 0.0000
714 WEIGHT INCREASED 11 0.0000
715 RHABDOMYOLYSIS 2 0.0000
716 PLATELET COUNT DECREASED 5 0.0000
717 RECTAL HAEMORRHAGE 2 0.0000
718 HYPOACUSIS 2 0.0000
719 SKIN CANCER 1 0.0000
720 FAECES DISCOLOURED 1 0.0000
721 SEPTIC SHOCK 2 0.0000
722 BLOOD PRESSURE INCREASED 7 0.0000
723 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
724 GLOSSODYNIA 1 0.0000
725 RASH PAPULAR 1 0.0000
726 CHROMATURIA 1 0.0000
727 DRUG INTERACTION 7 0.0000
728 PRODUCT AVAILABILITY ISSUE 1 0.0000
729 VISION BLURRED 6 0.0000
730 ABDOMINAL PAIN 10 0.0000
731 TREMOR 7 0.0000
732 PRODUCTIVE COUGH 2 0.0000
733 BLOOD PRESSURE FLUCTUATION 1 0.0000
734 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
735 DIABETIC KETOACIDOSIS 1 0.0000
736 MENTAL IMPAIRMENT 1 0.0000
737 ATRIAL FIBRILLATION 4 0.0000
738 DYSGEUSIA 3 0.0000
739 DIARRHOEA 26 0.0000
740 AGEUSIA 1 0.0000
741 DRY EYE 2 0.0000
742 PNEUMONIA ASPIRATION 1 0.0000
743 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
744 ABDOMINAL DISTENSION 4 0.0000
745 DEAFNESS 1 0.0000
746 ECZEMA 2 0.0000
747 SEDATION 1 0.0000
748 CONSTIPATION 8 0.0000
749 HAEMATOCHEZIA 2 0.0000
750 RESPIRATORY DISTRESS 1 0.0000
751 INFLUENZA 4 0.0000
752 PANCYTOPENIA 2 0.0000
753 THROMBOCYTOPENIA 4 0.0000
754 ASTHMA 4 0.0000
755 MUSCULAR WEAKNESS 4 0.0000
756 HYPOTENSION 7 0.0000
757 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
758 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
759 MUSCULOSKELETAL STIFFNESS 3 0.0000
760 LABORATORY TEST ABNORMAL 1 0.0000
761 WHEEZING 2 0.0000
762 HYPOAESTHESIA 5 0.0000
763 FALL 11 0.0000
764 OEDEMA PERIPHERAL 4 0.0000
765 DEATH 28 0.0000
766 LIMB DISCOMFORT 1 0.0000
767 HYPOTHYROIDISM 1 0.0000
768 RHINORRHOEA 2 0.0000
769 ALOPECIA 6 0.0000
770 PAIN IN EXTREMITY 9 0.0000
771 INJECTION SITE PRURITUS 2 0.0000
772 HEPATIC ENZYME INCREASED 2 0.0000
773 BURNING SENSATION 2 0.0000
774 SKIN BURNING SENSATION 2 0.0000
775 NO ADVERSE EVENT 5 0.0000
776 CRYING 1 0.0000
777 HYPERGLYCAEMIA 1 0.0000
778 UNDERDOSE 2 0.0000
779 AGITATION 2 0.0000
780 NASOPHARYNGITIS 5 0.0000
781 DYSARTHRIA 1 0.0000
782 HALLUCINATION 2 0.0000
783 ACNE 2 0.0000
784 ANAEMIA 5 0.0000
785 PERIPHERAL SWELLING 4 0.0000
786 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
787 CARDIAC FAILURE 2 0.0000
788 VISUAL IMPAIRMENT 3 0.0000
789 DRUG ABUSE 2 0.0000
790 POLLAKIURIA 1 0.0000
791 GASTROINTESTINAL DISORDER 2 0.0000
792 THERAPY NON-RESPONDER 1 0.0000
793 ADVERSE EVENT 2 0.0000
794 PNEUMONIA 7 0.0000
795 BREAST CANCER 2 0.0000
796 CARDIAC DISORDER 2 0.0000
797 SWELLING 2 0.0000
798 BLOOD GLUCOSE INCREASED 4 0.0000
799 INFECTION 3 0.0000
800 ABDOMINAL PAIN UPPER 4 0.0000
801 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
802 HAEMORRHAGE 2 0.0000
803 LETHARGY 1 0.0000
804 SURGERY 1 0.0000
805 NASAL CONGESTION 1 0.0000
806 IRRITABILITY 1 0.0000
807 PLEURAL EFFUSION 1 0.0000
808 MUSCLE SPASMS 3 0.0000
809 AMNESIA 1 0.0000
810 DRY SKIN 2 0.0000
811 MEMORY IMPAIRMENT 2 0.0000
812 DRUG INEFFECTIVE 19 0.0000
813 THERAPY INTERRUPTED 1 0.0000
814 ACUTE KIDNEY INJURY 2 0.0000
815 TOXICITY TO VARIOUS AGENTS 2 0.0000
816 SKIN EXFOLIATION 1 0.0000
817 URINARY TRACT INFECTION 2 0.0000
818 BALANCE DISORDER 1 0.0000
819 MIGRAINE 1 0.0000
820 HEART RATE INCREASED 1 0.0000
821 SINUSITIS 1 0.0000
822 OVERDOSE 2 0.0000
823 SEPSIS 1 0.0000
824 DECREASED APPETITE 2 0.0000
825 RENAL FAILURE 1 0.0000